Supriya Lifescience Limited

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7
Rok finansowy 2018 2019 2020 2021 2022 2023 2024 2025
Przychód (mln) 2,129 2,778 3,116 3,854 5,194 4,609 5,703 6,965
Przychód Δ r/r 0.0% 30.5% 12.2% 23.7% 34.8% -11.3% 23.7% 22.1%
Marża brutto 16.5% 37.5% 47.8% 60.8% 55.7% 60.8% 49.1% 55.2%
EBIT (mln) 167 611 1,008 1,664 2,043 1,172 1,572 2,404
EBIT Δ r/r 0.0% 266.1% 65.0% 65.1% 22.8% -42.7% 34.1% 52.9%
EBIT (%) 7.8% 22.0% 32.3% 43.2% 39.3% 25.4% 27.6% 34.5%
Koszty finansowe (mln) 0 102 68 41 42 31 21 17
EBITDA (mln) 267 725 1,090 1,782 2,216 1,384 1,836 2,706
EBITDA(%) 12.5% 26.1% 35.0% 46.2% 42.7% 30.0% 32.2% 38.9%
Podatek (mln) 57 177 228 436 554 336 466 605
Zysk Netto (mln) 87 394 734 1,236 1,518 899 1,191 1,880
Zysk netto Δ r/r 0.0% 351.7% 86.2% 68.4% 22.8% -40.8% 32.6% 57.8%
Zysk netto (%) 4.1% 14.2% 23.6% 32.1% 29.2% 19.5% 20.9% 27.0%
EPS 1.19 15.43 28.73 48.38 18.86 11.16 14.8 23.35
EPS (rozwodnione) 1.19 15.43 28.73 48.38 18.86 11.16 14.8 23.35
Ilośc akcji (mln) 73 26 26 26 80 80 80 80
Ważona ilośc akcji (mln) 73 26 26 26 80 80 80 80
Waluta INR INR INR INR INR INR INR INR